The simple steps that people with lupus and their families of the contracting reduce the likelihood of the contracting swine flu. Prevent individuals and family members who are ill and symptoms such as fever (over 100? Nausea, vomiting or diarrhea. Particular you particular you or to avoid face-to-face and personal contact, embrace that, shaking hands sildenafil . Wash your hands often. Can retain public areas, including public bathrooms, store worktops and restaurants the H1N1 virus. Use soapy water for at least 15 seconds, or wipe an alcohol when in public. Avoid touching your eyes, nose or mouth. Germs spread this way. Use to protect the elbow coughing and sneezing. Do not use your hands or handkerchiefs moisture that moisture that spread viruses in themselves. Stay home from work or school if you are sick you. Visit, While the symptoms of swine flu may vary from person to person, according to the World Health Organization, are common symptoms: high fever, cough and sore throat, symptoms similar to typical influenza, with some patients with diarrhea and vomiting. The cases can rapidly progress to severe and unusual pneumonia.
That people Flu Advisory for People with LupusThis note will be updated as more details from the Centers for Disease Control and Prevention received and will be determined by the Lupus Foundation of America Medical-Scientific Advisory Board. Please check has passed this announcement at regular intervals until this health problem.
TO NEXBIONexBio is to a privately held biopharmaceutical company develop San Diego. NexBio mission is to provide to saving lives and improve the lives by creating and commercializing new, broad-spectrum biopharmaceuticals prevent and treat existing and future life-threatening diseases. DAS181 )), a recombinant fusion protein that inactivates viral receptors on the cells in the human respiratory tract, thereby preventing under license from infection by flu, including any pandemic strains and with Parainfluenzaviren . In contrast to current antiviral compounds and vaccines, DAS181 targets human hosts receptor, no viral components and therefore contributes less risk of resistance to moment available antiviral drugs. Substantial, extended -clinical studies who development the development a sensible resistance. Viradin ), invented and developed by NexBio is a parental protein of in development that are currently in lead structure optimization Rank biothreat which to treating viral hemorrhagic fever and bacterial sepsis. TOSAP ) be one technology fictional and developed by NexBio and used for formulated DAS181 inhaled, as well as nano / the microparticles from virtually any type by molecular to make. TOSAP ) has offered for the formulation compounds of the partners that. Under license other things NOTICE:.